RWM
CLB icon

Rialto Wealth Management’s Core Laboratories CLB Stock Holding History

Rialto Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548 Buy
+47
New +$671 ﹤0.01% 1645

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rialto Wealth Management's CLB Position: Q2 2026 in Review

Rialto Wealth Management opened a new position in Core Laboratories (CLB) in Q2 2026: 47 shares worth $548. The stake represents ﹤0.01% of the portfolio and ranks #1645 among its holdings.

186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Rialto Wealth Management held 47 shares of Core Laboratories worth $548 as of Q2 2026.
  • Core Laboratories was a new Rialto Wealth Management position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1645 holding.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.